Repaglinide (Aurobindo Pharma Limited)
Welcome to the PulseAid listing for the Repaglinide drug offered from Aurobindo Pharma Limited. This Glinide [EPC],Potassium Channel Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Aurobindo Pharma Limited |
| NON-PROPRIETARY NAME: | Repaglinide |
| SUBSTANCE NAME: | REPAGLINIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Glinide [EPC],Potassium Channel Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2014-01-22 |
| END MARKETING DATE: | 0000-00-00 |
Repaglinide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Repaglinide from Aurobindo Pharma Limited |
| LABELER NAME: | Aurobindo Pharma Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/1) |
| START MARKETING DATE: | 2014-01-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 65862-670_0dd5f0e4-a7a3-476d-9bdc-c911fb9b7c4b |
| PRODUCT NDC: | 65862-670 |
| APPLICATION NUMBER: | ANDA203820 |
Other REPAGLINIDE Pharmaceutical Manufacturers / Labelers:
